The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The micropump market is expected to reach US$ 5,172.86 million in 2028 from as estimated value of US$ 1,553.01 million in 2021. The market is likely to grow with a CAGR of 18.8% from 2021-2028.
The scope of the Micropump market includes product type, material, application, end user, and region. Based on region, the Micropump market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the Micropump market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID–19 impact analysis across the regions.
To get sample Copy of the report, along with the TOC, Statistics @ https://www.theinsightpartners.com/sample/TIPRE00007338/
Here we have listed the top Micropump Market companies
Advanced Microfluidics, Microfluidica, LLC, Alldoo Micropump Co.,Ltd, Servoflo Corporation, TOPS INDUSTRY AND TECHNOLOGY CO. LTD, World Precision Instruments, Xavitech, Calon Cardio-Technology Ltd, Takasago Electric, Inc., Medtronic amongst others.
The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the Micropump. For instance, in Jan 2021, Medtronic has begun clinical studies for its 780G pump. The 780G is an advanced hybrid closed-loop system that employs a new algorithm that brings it one step closer to a genuine closed-loop automated insulin pump system, according to the manufacturer (artificial pancreas).
Highlights the following key factors:
1) Business description-A detailed description of the company’s operations and business divisions.
2) Corporate strategy – Analyst’s summarization of the company’s business strategy.
3) SWOT Analysis-A detailed analysis of the company’s strengths, weakness, opportunities, and threats.
4) Company history – Progression of key events associated with the company.
5) Major products and services-A list of major products, services, and brands of the company.
6) Key competitors – A list of key competitors to the company.
7) Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
8) Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 7 years history.
Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Micropump Market which would mention How the Covid-19 is Affecting the Micropump Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Micropump Players to fight Covid-19 Impact.
The micropump market, by product type is segmented into mechanical micropump, syringe pump, piezoelectric micropump, peristaltic pump, and non-mechanical micropump. The mechanical micropump segment held the largest share of the market in 2021, however the non-mechanical micropump segment is anticipated to register the highest CAGR of 19.7% in the market during the forecast period.
Micropump market based on material is segmented into silicon, polymer, glass. In 2021, the silicon segment is likely to hold the largest share of the market, however polymer segment is expected to grow at the fastest rate during the coming years.
The micropump market by end user, is segmented into hospitals & diagnostic centers, biotechnology & pharmaceutical companies, and academic & research institutes. The hospitals & diagnostic centers segment is likely to hold the largest share of the market in 2021 and is anticipated to register the highest CAGR of 19.3% of the market during the forecast period.
In recent years, controlled release of drugs has posed numerous challenges such as the release of the suitable quantity of drugs at the right time with the least invasiveness and raised demand for advanced drug delivery devices. Some of the factors that challenge conventional drug delivery devices include long-term treatments, narrow therapeutic windows, complex dosing schedules, combined therapies, and individual dosing regimens. The emergence of micro-electro-mechanical systems (MEMS) that combine mechanical and electrical components is providing solution to overcome these drawbacks.
Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00007338/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com